Marie Thibault
Stock Analyst at BTIG
(3.77)
# 732
Out of 5,124 analysts
103
Total ratings
51.04%
Success rate
8.71%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OM Outset Medical | Reiterates: Buy | $17 | $3.80 | +347.37% | 2 | Dec 16, 2025 | |
| CBLL CeriBell | Reiterates: Buy | $30 | $20.81 | +44.16% | 1 | Dec 15, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $100 → $103 | $84.17 | +22.37% | 2 | Dec 5, 2025 | |
| MASI Masimo | Maintains: Buy | $198 → $200 | $134.00 | +49.25% | 7 | Dec 4, 2025 | |
| HAE Haemonetics | Reiterates: Buy | $88 | $82.11 | +7.17% | 3 | Nov 21, 2025 | |
| BSX Boston Scientific | Reiterates: Buy | $132 | $95.48 | +38.25% | 14 | Nov 21, 2025 | |
| PODD Insulet | Maintains: Buy | $370 → $380 | $283.51 | +34.03% | 6 | Nov 21, 2025 | |
| ABT Abbott Laboratories | Reiterates: Buy | $145 | $126.45 | +14.67% | 14 | Nov 20, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $32 | $24.42 | +31.04% | 1 | Nov 18, 2025 | |
| ARAY Accuray | Maintains: Buy | $5 → $4 | $0.89 | +351.26% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $10.26 | +124.17% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $85 | $67.65 | +25.65% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $215 | $184.39 | +16.60% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.31 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $11.62 | +115.15% | 3 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.23 | - | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $58 → $52 | $40.55 | +28.25% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $65 | $66.43 | -2.15% | 8 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.82 | - | 2 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.52 | - | 3 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.41 | - | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.07 | - | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $333.03 | -98.20% | 1 | Apr 9, 2020 |
Outset Medical
Dec 16, 2025
Reiterates: Buy
Price Target: $17
Current: $3.80
Upside: +347.37%
CeriBell
Dec 15, 2025
Reiterates: Buy
Price Target: $30
Current: $20.81
Upside: +44.16%
Edwards Lifesciences
Dec 5, 2025
Maintains: Buy
Price Target: $100 → $103
Current: $84.17
Upside: +22.37%
Masimo
Dec 4, 2025
Maintains: Buy
Price Target: $198 → $200
Current: $134.00
Upside: +49.25%
Haemonetics
Nov 21, 2025
Reiterates: Buy
Price Target: $88
Current: $82.11
Upside: +7.17%
Boston Scientific
Nov 21, 2025
Reiterates: Buy
Price Target: $132
Current: $95.48
Upside: +38.25%
Insulet
Nov 21, 2025
Maintains: Buy
Price Target: $370 → $380
Current: $283.51
Upside: +34.03%
Abbott Laboratories
Nov 20, 2025
Reiterates: Buy
Price Target: $145
Current: $126.45
Upside: +14.67%
Kestra Medical Technologies
Nov 18, 2025
Initiates: Buy
Price Target: $32
Current: $24.42
Upside: +31.04%
Accuray
Nov 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.89
Upside: +351.26%
Nov 4, 2025
Reiterates: Buy
Price Target: $23
Current: $10.26
Upside: +124.17%
Oct 31, 2025
Maintains: Buy
Price Target: $109 → $85
Current: $67.65
Upside: +25.65%
Oct 31, 2025
Maintains: Buy
Price Target: $195 → $215
Current: $184.39
Upside: +16.60%
Oct 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.31
Upside: -
Sep 5, 2025
Reiterates: Buy
Price Target: $25
Current: $11.62
Upside: +115.15%
Aug 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.23
Upside: -
Apr 30, 2025
Maintains: Buy
Price Target: $58 → $52
Current: $40.55
Upside: +28.25%
Oct 14, 2024
Maintains: Buy
Price Target: $62 → $65
Current: $66.43
Upside: -2.15%
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.82
Upside: -
Oct 6, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.52
Upside: -
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.41
Upside: -
Jan 21, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.07
Upside: -
Apr 9, 2020
Maintains: Buy
Price Target: $11 → $6
Current: $333.03
Upside: -98.20%